论文部分内容阅读
对妇科肿瘤、子宫内膜异位症（子宫肌腺症）进行血清癌抗原125（CA125）、癌胚抗原（CEA）和甲胎蛋白（AFP）联合测定，旨在提高妇科肿瘤的诊断和鉴别诊断水平，对恶性肿瘤进行治疗监测，并对肿瘤标记物的敏感性和特异性进行探讨。1材料和方法对1996年1月～1998年6月妇科肿瘤13
Gynecologic oncology, endometriosis (uterine adenomyosis) serum cancer antigen 125 (CA125), carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) combined determination of gynecological oncology to improve the diagnosis and identification Diagnosis, treatment of malignant tumors monitoring, and the sensitivity and specificity of tumor markers to explore. 1 Materials and methods of gynecological tumors from January 1996 to June 1998 13